Form PRE 14A Alkermes plc. For: May 20
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20260327/AP2ZB22DZM2RK9ZZ2R2R2ZYNO3KDZZ22ZI82
Filed on: March 27, 2026
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alkermes (ALKS) PT Raised to $54 at Needham
- Organon Canada and Henlius Expand Access to Denosumab Treatments With Launch of BILDYOS® (denosumab injection) and TUZEMTY® (denosumab injection), Biosimilars to PROLIA and XGEVA
- Alkermes narcolepsy drug meets phase 2 trial endpoints
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
